CRH Medical Corp (TSE:CRH) received a C$6.50 price objective from equities researchers at RBC Capital Markets in a report issued on Thursday. The brokerage presently has a an “outperform” rating on the stock. RBC Capital Markets’ price target indicates a potential upside of 18.18% from the stock’s current price.

A number of other brokerages have also recently issued reports on CRH. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a C$6.50 price objective on shares of CRH Medical Corp in a research note on Thursday. CIBC reaffirmed an “outperform” rating on shares of CRH Medical Corp in a research note on Tuesday, September 13th.

Shares of CRH Medical Corp (TSE:CRH) traded up 3.64% on Thursday, hitting $5.70. 365,144 shares of the stock were exchanged. The company has a market cap of $408.48 million and a PE ratio of 69.51. CRH Medical Corp has a 12 month low of $2.94 and a 12 month high of $5.80. The company has a 50-day moving average price of $4.94 and a 200 day moving average price of $4.60.

Receive News & Stock Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related stocks with our FREE daily email newsletter.